What is sarcoma?

Hello I’m Grace Gawler.

I help patients navigate the complex cancer maze and I’ve had a lot of experience with sarcomas over the last 4 decades.

The term “sarcoma” encompasses a diverse and relatively rare group of malignant tumours that can affect soft tissue or bone throughout the body, and sometimes both.

Sarcoma cases constitute about 15 percent of all cancers in children, but are much rarer in adults and make up only about one percent of adult cancer cases.

If you have been directed to this page – you likely know what type of sarcoma you are managing. We invite you to consider the role of Personalised or Precision medicine when it comes to managing and treating your sarcoma. It is in your interest to learn about new diagnostic and treatment options – see recommended reading link below…

Recommended Reading click here

Book a Consultation with Grace to discuss your options:

My 43 years’ experience tells me that Sarcomas are notoriously “tricky” tumours and therefore are often misdiagnosed. Before now we have not had the diagnostic capability to go to deeper levels of diagnosis of Sarcomas.

Specific genomic testing targeted at sarcoma diagnosis is now available in Australia. We can assist you to connect with the only test used clinically in Australia for diagnosis and screening for sarcomas. As well tissue from other countries can be sent to Australia for testing.

Most of us have heard of genetics and how diseases can be inherited through genes passed down through our families. We know that genes work in groups and their activity is influenced by a huge variety of environmental and other factors.

We also now know that the DNA between your genes is also very important. Every healthy cell in your body has a complete set of genes. One set of all these genes (plus the DNA between the genes) is called a genome. Genomics is the study of the whole genome, what it’s made up of and how it works.

Sarcoma has an initial allocation of 500 genomes. Genomic testing can discover the nature your particular brand of sarcoma – and predict how well you will respond to a treatment or find one that will work best for you.

Genomic testing can also be used to test how well a cancer might respond to chemotherapy, radiotherapy or other treatment agents which translates to you the patient as Targeted treatment – rather than trial and error. The testing can identify molecular markers as well as specific genes, regions and pathways associated with tumour growth and progression in multiple sites, as well as tumour response and resistance to treatment.

Since sarcomas are too diverse to ignore – genomic diagnostics are highly recommended.
Your life depends on right diagnosis and right treatment.

The following story highlights the importance of genomic testing especially when the patient has endured a long history of misdiagnosis.
E.g. In 1998, a patient had gynaecological surgery for what they thought was a noncancerous fibroid. In 2003 she was diagnosed with an unknown metastatic tumour to the heart.

They called it a cancer of unknown primary (CUP) so treatment given was not specific. This led to many recurrences over the years. In 2016, she contacted Grace for Cancer Navigation Advice. After thorough lines of questioning,

Grace learned about the 1998 surgery. She organised a genomic diagnostic test which revealed it as the possible primary cancer site. The patient’s oncologist was advised and helped with further diagnostic investigation.

They found that the metastatic tumour to the heart & other tumours originated from the primary gynaecological cancer. This discovery changed the whole nature of her treatments. Targeted treatments were then identified.

Book a Consultation with Grace to discuss your options: